17alpah-alkyl-17beta-oxy-estratrienes and intermediate products for their production, uses thereof and pharmaceutical preparations

Details for Australian Patent Application No. 2006202187 (hide)

Owner Bayer Schering Pharma Aktiengesellschaft

Inventors Hoffmann, Jens; Reichel, Andreas; Jautelat, Rolf; Kroll, Jorg; Lichtner, Rosemarie; Bohlmann, Rolf; Heinrich, Nikolaus; Petrov, Orlin

Agent Davies Collison Cave

Pub. Number AU-B-2006202187

Parent 2004202428

Filing date 23 May 2006

Wipo publication date 15 June 2006

Acceptance publication date 6 November 2008

International Classifications

C07J 41/00 (2006.01) Normal steroids, i.e. cyclopenta[a]hydrophenanthrenes, containing nitrogen

A61K 31/567 (2006.01) - substituted in position 17 alpha, e.g. mestranol, norethandrolone

A61P 5/32 (2006.01) Drugs for disorders of the endocrine system

C07J 43/00 (2006.01) Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta[a]hydrophenanthrene skeleton

Event Publications

8 June 2006 Complete Application Filed

15 June 2006 Application Open to Public Inspection

  Published as AU-B-2006202187

9 October 2008 Alteration of Name

  The name of the applicant has been altered to Bayer Schering Pharma Aktiengesellschaft

6 November 2008 Application Accepted

  Published as AU-B-2006202187

5 March 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006202188-Aircraft warning system

2006202186-Modular Electrical Insert